• Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
  • Vimeo
  • NDT-Educational
NDT-Educational
  • ABOUT NDT-EDUCATIONAL
    • About NDT-Educational
    • About ERA-EDTA
    • Editorial Board
      • Davide Bolignano
      • Evangelia Ntounousi
      • Nuria Montero Perez
      • Francesco Trepiccione
      • Francesco Pesce
      • Björn Meijers
      • Mariusz Kusztal
      • Ana Carina Ferreira
      • Pietro Manuel Ferraro
  • NDT-EDUCATIONAL SUMMARY REPORTS
  • LONG REVIEWS
  • NDT-EDUCATIONAL NEWSLETTERS
  • NEWS
  • Search
  • Menu
  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
  • About NDT-Educational
    • About NDT-Educational
    • About the ERA-EDTA
    • Editorial Board
      • Davide Bolignano
      • Evangelia Ntounousi
      • Nuria Montero Perez
      • Francesco Trepiccione
      • Francesco Pesce
      • Björn Meijers
      • Mariusz Kusztal
      • Ana Carina Ferreira
      • Pietro Manuel Ferraro
  • NDT-Educational Summary Reports
  • LONG REVIEWS
  • NDT-Educational Newsletters
  • NEWS
  • MEMBERSHIP
  • My Era-Edta
  • Contact us

NDT-Educational Summary Reports

Biologics for glomerular diseases: success and disappointment from recent trials by Vladimir Tesar

7 January 2021/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2021/01/tesar.jpg 248 212 ERA-EDTA ERA-EDTA2021-01-07 14:20:212021-01-07 14:20:21Biologics for glomerular diseases: success and disappointment from recent trials by Vladimir Tesar

Chronic kidney disease of unknown etiology: population-level detection strategies by Marc De Broe and Benjamin Vervaet

10 December 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/12/debroe.png 280 206 ERA-EDTA ERA-EDTA2020-12-10 13:46:552020-12-10 13:46:55Chronic kidney disease of unknown etiology: population-level detection strategies by Marc De Broe and Benjamin Vervaet

Complement inhibition in glomerular diseases: is it enough or too much? by Giuseppe Remuzzi

26 November 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/11/remuzzi.jpg 209 210 ERA-EDTA ERA-EDTA2020-11-26 15:40:412020-11-26 15:40:41Complement inhibition in glomerular diseases: is it enough or too much? by Giuseppe Remuzzi

Formulas that estimate GFR in diabetes: can we trust them? by Esteban Porrini

29 October 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/10/porrini.png 210 210 ERA-EDTA ERA-EDTA2020-10-29 13:38:092020-10-29 13:38:09Formulas that estimate GFR in diabetes: can we trust them? by Esteban Porrini

Global epidemiology and outcomes of AKI with respect to CKD by Eric Adriaan J. Hoste

29 October 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/10/HOSTE.png 210 210 ERA-EDTA ERA-EDTA2020-10-29 13:37:322020-10-29 13:37:32Global epidemiology and outcomes of AKI with respect to CKD by Eric Adriaan J. Hoste

High Altitude Medicine by Gianfranco Parati

30 September 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/09/parati.png 250 250 ERA-EDTA ERA-EDTA2020-09-30 15:34:392020-09-30 15:34:39High Altitude Medicine by Gianfranco Parati

HDF versus medium cut-off dialyzers by Francisco Maduell

30 September 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/09/Francisco_Maduell.jpg 250 250 ERA-EDTA ERA-EDTA2020-09-30 15:34:262020-09-30 15:50:28HDF versus medium cut-off dialyzers by Francisco Maduell

Nutrition in patients with AKI: does it matter? by Enrico Fiaccadori

18 September 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/09/fiaccadori.jpg 256 256 ERA-EDTA ERA-EDTA2020-09-18 15:26:282020-09-18 15:26:28Nutrition in patients with AKI: does it matter? by Enrico Fiaccadori

How to choose the right dialysis access for an individual patient by Maurizio Gallieni

3 September 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/09/gallieni.png 200 201 ERA-EDTA ERA-EDTA2020-09-03 10:32:462020-09-03 10:32:46How to choose the right dialysis access for an individual patient by Maurizio Gallieni

Should I change my daily practice in the treatment of lupus nephritis with new drugs for SLE? by Gabriella Moroni

3 September 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/04/moroni-1.png 209 200 ERA-EDTA ERA-EDTA2020-09-03 09:26:232020-09-03 09:26:23Should I change my daily practice in the treatment of lupus nephritis with new drugs for SLE? by Gabriella Moroni

AKI in Covid-19 patients: mechanisms and management by Claudio Ronco

20 August 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/08/ronco.jpg 250 253 ERA-EDTA ERA-EDTA2020-08-20 10:57:192020-08-20 15:51:29AKI in Covid-19 patients: mechanisms and management by Claudio Ronco

Treatment of dyslipidemia in CKD: where do we stand now? by Charles Ferro

20 August 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/08/ferro2020.jpg 291 328 ERA-EDTA ERA-EDTA2020-08-20 10:53:362020-08-20 11:07:58Treatment of dyslipidemia in CKD: where do we stand now? by Charles Ferro

Vitamin K in CKD patients: metabolism and therapeutic aspects by Jürgen Floege

22 July 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/07/floege2020.jpg 239 228 ERA-EDTA ERA-EDTA2020-07-22 11:49:412020-07-22 12:41:36Vitamin K in CKD patients: metabolism and therapeutic aspects by Jürgen Floege

Corticosteroids as first treatment in MCD, FSGS and IgAN: when and how. Long term side effects by Claudio Ponticelli

22 July 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/07/ponticelli2020.jpg 213 210 ERA-EDTA ERA-EDTA2020-07-22 11:38:542020-07-22 11:38:54Corticosteroids as first treatment in MCD, FSGS and IgAN: when and how. Long term side effects by Claudio Ponticelli

SGLT2 inhibition in CKD: Our chance to make a difference – Organised by CHANGE IME in partnership with Leicester Diabetes Centre, funded by an unrestricted educational grant from AstraZeneca

8 July 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/07/2020_logo_400.png 400 359 ERA-EDTA ERA-EDTA2020-07-08 16:22:212020-07-10 10:33:19SGLT2 inhibition in CKD: Our chance to make a difference – Organised by CHANGE IME in partnership with Leicester Diabetes Centre, funded by an unrestricted educational grant from AstraZeneca

Clinical Conundrums in aTypical HUS – Organised by ALEXION PHARMA GMBH

2 July 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/07/2020_logo_400.png 400 359 ERA-EDTA ERA-EDTA2020-07-02 15:56:592020-07-09 12:44:58Clinical Conundrums in aTypical HUS - Organised by ALEXION PHARMA GMBH

K+: Recurrence, Restriction and Fluctuation. Organised by CHANGE IME in partnership with Leicester Diabetes Centre, funded by an unrestricted educational grant from AstraZeneca

2 July 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/07/2020_logo_400.png 400 359 ERA-EDTA ERA-EDTA2020-07-02 15:56:242020-07-10 10:50:08K+: Recurrence, Restriction and Fluctuation. Organised by CHANGE IME in partnership with Leicester Diabetes Centre, funded by an unrestricted educational grant from AstraZeneca

Expert approaches to management across the CKD-MBD continuum – Organised by Vifor Fresenius Medical Care Renal Pharma Ltd.

2 July 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/07/2020_logo_400.png 400 359 ERA-EDTA ERA-EDTA2020-07-02 15:54:582020-07-09 12:45:12Expert approaches to management across the CKD-MBD continuum - Organised by Vifor Fresenius Medical Care Renal Pharma Ltd.

COVID-19 Registry – the Spanish experience by Emilio Sanchez

18 May 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/05/ES-280x280.jpg 280 280 ERA-EDTA ERA-EDTA2020-05-18 17:26:232020-05-18 17:26:23COVID-19 Registry - the Spanish experience by Emilio Sanchez

COVID-19 infection – Some implications for nephrology by Annette Bruchfeld

18 May 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/05/bruchfeld.jpg 394 400 ERA-EDTA ERA-EDTA2020-05-18 17:25:472020-05-18 17:25:47COVID-19 infection – Some implications for nephrology by Annette Bruchfeld

COVID-19 and ACE inhibitors and ARBs by Patrick Mark

18 May 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/05/Patrick-Mark.jpg 321 300 ERA-EDTA ERA-EDTA2020-05-18 17:25:102020-05-18 17:25:10COVID-19 and ACE inhibitors and ARBs by Patrick Mark

Personalized diagnosis and CKD prediction in genetic tubular disorders by Francesca Becherucci

17 April 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/04/Francesca_Becherucci_200.jpg 200 200 ERA-EDTA ERA-EDTA2020-04-17 10:15:392020-04-17 10:15:39Personalized diagnosis and CKD prediction in genetic tubular disorders by Francesca Becherucci

Biologic therapy in lupus nephritis – where are we now? by Gabriella Moroni

17 April 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/04/moroni-1.png 209 200 ERA-EDTA ERA-EDTA2020-04-17 09:45:322020-04-17 09:45:32Biologic therapy in lupus nephritis – where are we now? by Gabriella Moroni

New insights into pathogenesis and treatment of vascular calcification by Catherine Shanahan

16 April 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/04/CathyShanahan-1.jpg 227 200 ERA-EDTA ERA-EDTA2020-04-16 15:38:342020-04-16 15:38:34New insights into pathogenesis and treatment of vascular calcification by Catherine Shanahan

Histologic classification of lupus nephritis – time for a change by Ingeborg M. Bajema

16 March 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/03/bajema.jpg 285 300 ERA-EDTA ERA-EDTA2020-03-16 11:35:232020-03-16 11:35:23Histologic classification of lupus nephritis – time for a change by Ingeborg M. Bajema

Small solute clearance: what are the pitfalls? by Enric Vilar

16 March 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/03/vilar.jpg 316 300 ERA-EDTA ERA-EDTA2020-03-16 09:59:502020-03-16 09:59:50Small solute clearance: what are the pitfalls? by Enric Vilar

New therapeutic targets in Alport syndrome by Roser Torra

28 February 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Roser_Torra.jpg 400 400 ERA-EDTA ERA-EDTA2020-02-28 11:51:292020-02-28 11:51:29New therapeutic targets in Alport syndrome by Roser Torra

Phosphate toxicity in the kidney by Carsten Wagner

28 February 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/02/wagner.jpg 335 333 ERA-EDTA ERA-EDTA2020-02-28 11:51:022020-02-28 11:51:02Phosphate toxicity in the kidney by Carsten Wagner

Vascular access : the Achilles tendon in HHD?

14 February 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/02/2020-02-14_10-46.jpg 332 317 ERA-EDTA ERA-EDTA2020-02-14 11:20:272020-02-14 12:19:41Vascular access : the Achilles tendon in HHD?

Bariatric surgery: untangling the links between diabetes, hypertension and kidney disease?

14 February 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/02/2020-02-14_09-45.jpg 343 309 ERA-EDTA ERA-EDTA2020-02-14 10:41:542020-02-14 10:41:54Bariatric surgery: untangling the links between diabetes, hypertension and kidney disease?

Which method to measure GFR and in which clinical conditions?

31 January 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/01/delanaye.jpg 366 288 ERA-EDTA ERA-EDTA2020-01-31 15:32:012020-01-31 15:32:01Which method to measure GFR and in which clinical conditions?

What is the optimal approach to the treatment of IgA nephropathy in 2019?

31 January 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/01/floege.jpg 320 253 ERA-EDTA ERA-EDTA2020-01-31 14:20:482020-01-31 15:33:21What is the optimal approach to the treatment of IgA nephropathy in 2019?

Outcomes of frail patients after kidney transplantation

17 January 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/01/2020-01-17_15-45.jpg 358 337 ERA-EDTA ERA-EDTA2020-01-17 18:38:472020-01-17 18:38:47Outcomes of frail patients after kidney transplantation

ANCA-associated vasculitis in the elderly and very elderly

17 January 2020/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2020/01/2020-01-17_15-16.jpg 367 340 ERA-EDTA ERA-EDTA2020-01-17 15:34:242020-01-17 15:34:24ANCA-associated vasculitis in the elderly and very elderly

Special issues of AKI and CKD in low and middle income countries by Mehmet Sukru Sever

3 December 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/12/sever.png 281 281 ERA-EDTA ERA-EDTA2019-12-03 09:24:492019-12-10 12:38:54Special issues of AKI and CKD in low and middle income countries by Mehmet Sukru Sever

Why is the risk of stroke so high in CKD and in dialysis patients? by Sydney Tang

3 December 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/12/Sydney-Tang_300.jpg 300 300 ERA-EDTA ERA-EDTA2019-12-03 08:58:392019-12-03 08:59:19Why is the risk of stroke so high in CKD and in dialysis patients? by Sydney Tang

Is it time to consider dialysis withdrawal? by Monika Lichodziejewska-Niemierko

31 October 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/75a805b5208b2c55b94d14e3b4800da1file.jpeg 400 400 ERA-EDTA ERA-EDTA2019-10-31 14:07:422019-11-20 14:22:02Is it time to consider dialysis withdrawal? by Monika Lichodziejewska-Niemierko

Therapeutic management of cystinuria: today and tomorrow by John Andrew Sayer

31 October 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/sayer.jpeg 400 400 ERA-EDTA ERA-EDTA2019-10-31 13:43:312019-11-20 14:01:40Therapeutic management of cystinuria: today and tomorrow by John Andrew Sayer

Kidney protection in living donors by Charles Ferro

19 October 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/ferro.jpg 400 400 ERA-EDTA ERA-EDTA2019-10-19 13:36:152019-11-20 13:43:02Kidney protection in living donors by Charles Ferro

Oxidative stress on myocardial function in CKD by Leticia Prates Roma

19 October 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/leticiaroma.jfif_.png 400 400 ERA-EDTA ERA-EDTA2019-10-19 13:24:312019-11-20 13:35:21Oxidative stress on myocardial function in CKD by Leticia Prates Roma

Addressing potentially inappropriate medications in older adults with kidney disease by Rasheeda Hall

5 October 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/i2527072.jpg 300 235 ERA-EDTA ERA-EDTA2019-10-05 11:42:452019-11-20 11:52:53Addressing potentially inappropriate medications in older adults with kidney disease by Rasheeda Hall

Peritoneal dialysis adequacy and outcomes: what really matters? by Isaac Teitelbaum

5 October 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/10/Isaac_Teitelbaum.jpg 512 512 ERA-EDTA ERA-EDTA2019-10-05 11:34:562019-11-20 11:42:10Peritoneal dialysis adequacy and outcomes: what really matters? by Isaac Teitelbaum

Gut microbiota and microbial metabolism in CKD across stages of disease by Griet Glorieux

20 September 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/10/fil228e.png 267 267 ERA-EDTA ERA-EDTA2019-09-20 16:34:232019-11-20 11:09:11Gut microbiota and microbial metabolism in CKD across stages of disease by Griet Glorieux

Muscle protein turnover and low protein diet in patients with CKD by Giacomo Garibotto

20 September 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/fil118e.png 270 270 ERA-EDTA ERA-EDTA2019-09-20 11:09:462019-11-20 11:17:52Muscle protein turnover and low protein diet in patients with CKD by Giacomo Garibotto

Dietary Acid Reduction and Kidney Protection: Adjunctive Benefits When Done with Fruits and Vegetables by Donald E. Wesson

6 September 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/wesson.png 248 248 ERA-EDTA ERA-EDTA2019-09-06 11:02:232019-11-20 11:28:39Dietary Acid Reduction and Kidney Protection: Adjunctive Benefits When Done with Fruits and Vegetables by Donald E. Wesson

The Concept of Incremental Dialysis by Carlo Basile

6 September 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/foto-carlo-basile.jpg 256 256 ERA-EDTA ERA-EDTA2019-09-06 10:50:022019-11-20 11:28:05The Concept of Incremental Dialysis by Carlo Basile

AKI in austere environments by Valerie A. Luyckx

19 July 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/luyckx.jpeg 225 225 ERA-EDTA ERA-EDTA2019-07-19 18:00:122019-11-20 11:29:16AKI in austere environments by Valerie A. Luyckx

Do we still need calcineurin inhibitors in 2018? by Daniel Abramowicz

7 June 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Abramowicz.png 400 400 ERA-EDTA ERA-EDTA2019-06-07 17:11:302019-11-20 11:29:48Do we still need calcineurin inhibitors in 2018? by Daniel Abramowicz

Consulting the patient with AKI in other clinics: What should be stressed by a nephrologist? by Mustafa Arici

23 May 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Arici_400.png 400 400 ERA-EDTA ERA-EDTA2019-05-23 13:54:252019-11-20 11:30:19Consulting the patient with AKI in other clinics: What should be stressed by a nephrologist? by Mustafa Arici

Cyclophosphamide: the case of lupus nephritis – Should we still be using this old drug or does it have to be abandoned? by Vladimir Tesar

9 May 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/tesar.jpg 361 400 ERA-EDTA ERA-EDTA2019-05-09 13:31:302019-11-20 11:31:03Cyclophosphamide: the case of lupus nephritis - Should we still be using this old drug or does it have to be abandoned? by Vladimir Tesar

Continuous renal replacement therapy by Roser Torra

9 May 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Roser_Torra.jpg 400 400 ERA-EDTA ERA-EDTA2019-05-09 12:39:282019-11-20 11:31:32Continuous renal replacement therapy by Roser Torra

Continuous renal replacement therapy by Esteban Poch

25 April 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/dr_esteban_poch_1551175195115_a356356.jpg 290 290 ERA-EDTA ERA-EDTA2019-04-25 12:06:392019-11-20 11:31:58Continuous renal replacement therapy by Esteban Poch

From the RNA world to the clinic:​ RNAs as drugs and drug targets by Bruce A. Sullenger

25 April 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/bruce_sullenger-r-290x290.jpg 290 290 ERA-EDTA ERA-EDTA2019-04-25 10:36:472019-11-20 11:32:25From the RNA world to the clinic:​ RNAs as drugs and drug targets by Bruce A. Sullenger

Anti-GBM disease: New subgroups and novel therapies by Martin Segelmark

11 April 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Marten-segelmark.jpg 432 400 ERA-EDTA ERA-EDTA2019-04-11 18:50:182019-11-20 11:32:47Anti-GBM disease: New subgroups and novel therapies by Martin Segelmark

Back from the future – Lowering oral steroids in lupus therapy by Guillermo Ruiz-Irastorza

11 April 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Guillermo-Ruiz-Irastorza-Internista.png 400 400 ERA-EDTA ERA-EDTA2019-04-11 18:31:072019-11-20 11:33:22Back from the future – Lowering oral steroids in lupus therapy by Guillermo Ruiz-Irastorza

Klotho and endocrine FGFs – marker of CKD progression and cardiovascular complications? By Makoto Kuro-o

28 March 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/kuroo.jpg 405 400 ERA-EDTA ERA-EDTA2019-03-28 17:28:492019-11-11 15:19:53Klotho and endocrine FGFs – marker of CKD progression and cardiovascular complications? By Makoto Kuro-o

Inflammation in crystal nephropathies by Hans-Joachim Anders

28 March 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/hj-awards.png 300 300 ERA-EDTA ERA-EDTA2019-03-28 16:02:432019-11-11 15:20:47Inflammation in crystal nephropathies by Hans-Joachim Anders

New paradigms of the Kidney-Bone-Vascular axis in CKD by Klaus Olgaard

14 March 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Olgaard.jpg 300 300 ERA-EDTA ERA-EDTA2019-03-14 19:09:462019-11-11 15:24:07New paradigms of the Kidney-Bone-Vascular axis in CKD by Klaus Olgaard

The conundrum of treating gout in patients with CKD by Jazub Zavada

14 March 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/zavada300.jpg 300 300 ERA-EDTA ERA-EDTA2019-03-14 18:43:172019-11-11 15:24:53The conundrum of treating gout in patients with CKD by Jazub Zavada

Can antidiabetic drugs prevent chronic kidney disease progression? By Christoph Wanner

28 February 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Wanner-ERA-EDTA_awards_2016.jpg 250 250 ERA-EDTA ERA-EDTA2019-02-28 17:44:002019-11-11 15:25:52Can antidiabetic drugs prevent chronic kidney disease progression? By Christoph Wanner

Newer agents in the treatment of SLE nephritis by David Jayne

28 February 2019/in NDT-E Summary Articles /by ERA-EDTA
Read more
https://www.era-edta.org/en/ndt-educational/wp-content/uploads/sites/9/2019/11/Jayne.jpg 668 800 ERA-EDTA ERA-EDTA2019-02-28 16:13:042019-11-11 15:26:23Newer agents in the treatment of SLE nephritis by David Jayne

ERA-EDTA Operative Headquarters
Via XXIV Maggio 38
43123 Parma – Italy
Phone: +39 0521 989078
Fax: +39 0521 959242
E-mail: secretariat@era-edta.org

ERA-EDTA Registered Office
c/o PKF Littlejohn, 15 Westferry Circus, Canary Wharf
London E14 4HD – United Kingdom

You are here: Home / NDT-Educational Summary Reports

  • ABOUT ERA-EDTA
  • CONGRESS & MEETINGS
  • JOURNAL & PRESS
  • EDUCATION
  • PUBBLIC AFFAIRS
  • GUIDELINES

  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
© Copyright - Era-Edta
  • Terms & conditions
  • Cookie Policy
  • Privacy Policy
  • Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
  • Vimeo
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKLearn more